肠易激综合征：综述与更新
Irritable bowel syndrome: a review and update.
作者信息
Occhipinti Kaitlin, Smith James W
机构信息
Department of Gastroenterology, Ochsner Clinic Foundation, New Orleans, Louisiana.
出版信息
Clin Colon Rectal Surg. 2012 Mar;25(1):46-52. doi: 10.1055/s-0032-1301759.
Abstract
The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with scientific advancement. IBS is a common functional bowel disorder that generates a significant health care burden and is the most commonly diagnosed gastrointestinal condition. There are well-established diagnostic criteria and algorithms for the initial evaluation of patients presenting with the symptoms of IBS. The symptoms can be targeted for therapy with a variety of pharmaceutical and nonpharmaceutical agents. Therapy should be individualized for the patient, and the cornerstone for any effective treatment strategy should be the solid patient-physician relationship.
摘要
随着科学的进步，对肠易激综合征（IBS）的认识经历了快速的演变。IBS是一种常见的功能性肠道疾病，会产生重大的医疗负担，并且是最常被诊断出的胃肠道疾病。对于出现IBS症状的患者，有成熟的诊断标准和算法用于初始评估。可以使用多种药物和非药物制剂针对症状进行治疗。治疗应针对患者个体化，任何有效治疗策略的基石都应该是牢固的医患关系。
相似文献
1
Irritable bowel syndrome: a review and update.肠易激综合征：综述与更新
Clin Colon Rectal Surg. 2012 Mar;25(1):46-52. doi: 10.1055/s-0032-1301759.
2
Medical treatment of irritable bowel syndrome.肠易激综合征的医学治疗
Clin Colon Rectal Surg. 2005 May;18(2):102-8. doi: 10.1055/s-2005-870891.
4
Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions.肠易激综合征亚型：旧疾新名。
Dig Dis. 2020;38(2):122-127. doi: 10.1159/000505287. Epub 2019 Dec 18.
5
Update on Pharmacotherapy for Irritable Bowel Syndrome.肠易激综合征药物治疗的最新进展
Curr Gastroenterol Rep. 2019 Apr 25;21(6):25. doi: 10.1007/s11894-019-0692-7.
6
Irritable bowel syndrome: update on pathogenesis and management.肠易激综合征：发病机制与管理的最新进展
Med Princ Pract. 2002 Jan-Mar;11(1):2-17. doi: 10.1159/000048654.
7
Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.罗马标准与肠易激综合征的诊断方法
J Clin Med. 2017 Oct 26;6(11):99. doi: 10.3390/jcm6110099.
8
Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.患有肠易激综合征的患者，精神和躯体共病的类型（而非数量）会增加其症状的严重程度。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1147-57. doi: 10.1016/j.cgh.2013.03.011. Epub 2013 Mar 21.
9
Increased risk for irritable bowel syndrome after acute diverticulitis.急性憩室炎后肠易激综合征风险增加。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1614-9. doi: 10.1016/j.cgh.2013.03.007. Epub 2013 Mar 21.
10
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.关于 Eluxadoline 治疗腹泻型肠易激综合征的最新进展：患者选择和观点。
Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020.
引用本文的文献
1
Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome.用于治疗强迫症的深部脑刺激会导致共病的肠易激综合征出现症状变化。
Front Psychiatry. 2025 Mar 5;16:1545318. doi: 10.3389/fpsyt.2025.1545318. eCollection 2025.
2
Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.克罗恩病、肠易激综合征与慢性疲劳：沟通及症状管理的重要性——一例病例报告
J Med Case Rep. 2025 Jan 9;19(1):9. doi: 10.1186/s13256-024-05010-3.
3
Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.肠易激综合征患者肠道微生物群改变的荟萃分析。
Front Microbiol. 2024 Dec 24;15:1492349. doi: 10.3389/fmicb.2024.1492349. eCollection 2024.
4
Transcriptomic Module Discovery of Diarrhea-Predominant Irritable Bowel Syndrome: A Causal Network Inference Approach.腹泻型肠易激综合征的转录组模块发现：一种因果网络推断方法。
Int J Mol Sci. 2024 Aug 28;25(17):9322. doi: 10.3390/ijms25179322.
5
Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.神经调节与肠-脑轴：治疗机制及其对胃肠道和神经系统疾病的影响
Pathophysiology. 2024 May 17;31(2):244-268. doi: 10.3390/pathophysiology31020019.
6
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS.肠神经系统中长期的隐性表观遗传应激信息及其对 IBS 发展和持续的贡献。
Curr Neuropharmacol. 2024;22(13):2100-2112. doi: 10.2174/1570159X22666240507095700.
7
Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.比较跨诊断治疗与接受和承诺疗法对肠易激综合征患者情绪障碍、反刍思维和生活满意度的疗效：一项随机临床试验。
BMC Gastroenterol. 2024 Feb 6;24(1):66. doi: 10.1186/s12876-024-03142-w.
8
Exploring the Nutrition Strategies Employed by Ultra-Endurance Athletes to Alleviate Exercise-Induced Gastrointestinal Symptoms-A Systematic Review.探索超耐力运动员缓解运动引起的胃肠道症状所采用的营养策略——系统评价。
Nutrients. 2023 Oct 11;15(20):4330. doi: 10.3390/nu15204330.
9
Is Irritable Bowel Syndrome out of date and misleading as a diagnosis?肠易激综合征作为一种诊断是否过时且具有误导性？
Gastroenterol Hepatol Bed Bench. 2023;16(2):210-216. doi: 10.22037/ghfbb.v16i2.2761.
10
Unconventional but effective: breaking through IBS-D clinical practice guidelines - correspondence.非传统但有效：突破肠易激综合征腹泻型临床实践指南——通信
Ann Med Surg (Lond). 2023 Mar 27;85(4):1312-1313. doi: 10.1097/MS9.0000000000000338. eCollection 2023 Apr.
本文引用的文献
1
Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.正念训练可降低女性肠易激综合征的严重程度：一项随机对照试验的结果。
Am J Gastroenterol. 2011 Sep;106(9):1678-88. doi: 10.1038/ajg.2011.184. Epub 2011 Jun 21.
2
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.无麸质饮食并不会改善非乳糜泻患者的胃肠道症状：一项双盲、随机、安慰剂对照试验。
Am J Gastroenterol. 2011 Mar;106(3):508-14; quiz 515. doi: 10.1038/ajg.2010.487. Epub 2011 Jan 11.
3
Rifaximin therapy for patients with irritable bowel syndrome without constipation.利福昔明治疗无便秘型肠易激综合征患者。
N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409.
4
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.饮食中短链碳水化合物的操纵改变了肠易激综合征气体产生和症状发生的模式。
J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73. doi: 10.1111/j.1440-1746.2010.06370.x.
5
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.基层医疗中，可溶或不可溶纤维用于肠易激综合征？随机安慰剂对照试验。
BMJ. 2009 Aug 27;339:b3154. doi: 10.1136/bmj.b3154.
6
An evidence-based position statement on the management of irritable bowel syndrome.关于肠易激综合征管理的循证立场声明。
Am J Gastroenterol. 2009 Jan;104 Suppl 1:S1-35. doi: 10.1038/ajg.2008.122.
7
The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.肠溶性、迟释型薄荷油对肠易激综合征的影响。
Dig Dis Sci. 2010 May;55(5):1385-90. doi: 10.1007/s10620-009-0854-9. Epub 2009 Jun 9.
8
The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.益生菌在肠易激综合征治疗中的应用：一项系统评价。
Am J Gastroenterol. 2009 Apr;104(4):1033-49; quiz 1050. doi: 10.1038/ajg.2009.25. Epub 2009 Mar 10.
9
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.临床试验：鲁比前列酮治疗便秘型肠易激综合征患者——两项随机、安慰剂对照研究的结果
Aliment Pharmacol Ther. 2009 Feb 1;29(3):329-41. doi: 10.1111/j.1365-2036.2008.03881.x. Epub 2008 Nov 4.
10
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.抗抑郁药和心理疗法治疗肠易激综合征的疗效：系统评价与荟萃分析。
Gut. 2009 Mar;58(3):367-78. doi: 10.1136/gut.2008.163162. Epub 2008 Nov 10.
Zotero 插件